FAKTOR OPTIONSSCHEIN - DEXCOM Stock

DE000PE4DEX6

Delayed Deutsche Boerse AG 09:20:24 2024-07-17 am EDT
20.34 ^EUR	-3.10%

Current month	+6.66%
1 month	-7.29%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Leerink Adjusts Price Target on DexCom to $151 From $161	09:28am	MT
Morgan Stanley Cuts Price Target on DexCom to $120 From $132, Keeps Equalweight Rating	Jul. 15	MT
Stifel Adjusts Price Target on DexCom to $132 From $145	Jul. 12	MT
UPC Issues Two First Instance Decisions On Infringement	Jul. 11	AQ

More news

Quotes 5-day view

Date	Price	Change
24-07-17	20.34	-3.10%
24-07-16	20.99	+11.12%
24-07-15	18.89	-6.62%
24-07-12	20.23	+6.14%
24-07-11	19.06	+6.78%

Delayed Quote Deutsche Boerse AG

Last update July 17, 2024 at 09:20 am EDT

More quotes

Static data

Product type	Produits Exotiques
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	BNP Paribas
WKN	PE4DEX
ISIN	DE000PE4DEX6
Date issued	2022-09-28
Strike	116.1 $
Maturity	Unlimited
Parity	1 : 1
Emission price	50 €
Emission volume	N/A
Settlement	règlement en espèces
Currency	EUR

Technical Indicators

Highest since issue	197.3 €
Lowest since issue	8.8 €
Spread	1.21 €
Spread %	5.62%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

116.1 USD

Average target price

149.3 USD

Spread / Average Target

+28.64%

Consensus